These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9555114)

  • 1. P53 expression in stage I squamous cell lung cancer.
    Moldvay J; Strausz J; Egerváry M; Agócs L; Bocsi J; Schaff Z
    Pathol Oncol Res; 1998; 4(1):8-13. PubMed ID: 9555114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
    Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
    Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
    Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Di Carlo L; Semeraro A; Daddi G; Darwish S; Stocchi L; Tofanetti FR; Bellezza G; Sidoni A; Tognellini R; Crinò L; Tonato M
    Tumori; 2008; 94(3):398-405. PubMed ID: 18705409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and clinical significance of p53 protein and p21(WAF1) in non-small-cell lung carcinoma].
    Zhang H; Lü F; Yue W; Yan H; Deng L; Wang S
    Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):328-30. PubMed ID: 11866928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p16 and p53 in non-small-cell lung cancer: clinicopathological correlation and potential prognostic impact.
    Zhou Y; Höti N; Ao M; Zhang Z; Zhu H; Li L; Askin F; Gabrielson E; Zhang H; Li QK
    Biomark Med; 2019 Jun; 13(9):761-771. PubMed ID: 31157548
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.
    Lee JS; Yoon A; Kalapurakal SK; Ro JY; Lee JJ; Tu N; Hittelman WN; Hong WK
    J Clin Oncol; 1995 Aug; 13(8):1893-903. PubMed ID: 7636531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maspin, VEGF and p53 expression in small biopsies of primary advanced lung cancer and relationship with clinicopathologic parameters.
    Bircan A; Bircan S; Kapucuoglu N; Songur N; Ozturk O; Akkaya A
    Pathol Oncol Res; 2010 Dec; 16(4):553-61. PubMed ID: 20349288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the p53 family in lung cancer.
    Uramoto H; Sugio K; Oyama T; Nakata S; Ono K; Nozoe T; Yasumoto K
    Anticancer Res; 2006; 26(3A):1785-90. PubMed ID: 16827107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53.
    Hirabayashi H; Ohta M; Tanaka H; Sakaguchi M; Fujii Y; Miyoshi S; Matsuda H
    J Surg Oncol; 2002 Dec; 81(4):177-84; discussion 184. PubMed ID: 12451621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma.
    Xu HJ; Quinlan DC; Davidson AG; Hu SX; Summers CL; Li J; Benedict WF
    J Natl Cancer Inst; 1994 May; 86(9):695-9. PubMed ID: 8158700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity and Bcl-2 expression in non-small cell lung cancer.
    Ohmura Y; Aoe M; Andou A; Shimizu N
    Clin Cancer Res; 2000 Aug; 6(8):2980-7. PubMed ID: 10955774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 protein immunoexpression in esophageal squamous cell carcinoma and adjacent epithelium.
    Chaves P; Pereira AD; Pinto A; Oliveira AG; Queimado L; Gloria L; Cardoso P; Mira FC; Soares J
    J Surg Oncol; 1997 May; 65(1):3-9. PubMed ID: 9179260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
    Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of p21 protein expression in patients with pulmonary squamous cell carcinoma following induction chemotherapy.
    Tamura M; Sawabata N; Kobayashi S; Umezu H; Seki N; Yoshii N; Karube Y; Araki O; Ishihama H; Nagai S; Miyoshi S
    Ann Thorac Cardiovasc Surg; 2007 Feb; 13(1):9-14. PubMed ID: 17392664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors.
    Saemi N; Khoshnevis J; Akbari ME; Meysamie A; Korourian A; Gholizadeh B; Larijani L; Moradi A; Baikpour M; Baikpour M; Zham H
    J Gastrointest Cancer; 2018 Mar; 49(1):35-40. PubMed ID: 27975182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy.
    Jain D; Srinivasan R; Patel FD; Kumari Gupta S
    Gynecol Oncol; 2003 Jan; 88(1):22-8. PubMed ID: 12504622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
    Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
    Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of p53 protein and X-ray repair cross-complementing protein 1 in non-small cell lung cancer.
    Rybárová S; Hodorová I; Muri J; Mihalik J; Adamkov M; Svajdler M; Piovarci D; Mirossay L
    Tumori; 2011; 97(1):79-85. PubMed ID: 21528669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.